Literature DB >> 15621263

Pharmacologically active microcarriers: a tool for cell therapy.

V M Tatard1, M C Venier-Julienne, P Saulnier, E Prechter, J P Benoit, P Menei, C N Montero-Menei.   

Abstract

To overcome certain problems encountered in cell therapy, particularly cell survival, lack of cell differentiation and integration in the host tissue, we developed pharmacologically active microcarriers (PAM). These biodegradable particles made with poly(D,L-lactic-co-glycolic acid) (PLGA) and coated with adhesion molecules may serve as a support for cell culture and may be used as cell carriers presenting a controlled delivery of active protein. They can thus support the survival and differentiation of the transported cells as well as their microenvironment. To develop this tool, nerve growth factor (NGF)-releasing PAM, conveying PC12 cells, were produced and characterized. Indeed, these cells have the ability to differentiate into sympathetic-like neurons after adhering to a substrate, in the presence of NGF, and can then release large amounts of dopamine. Certain parameters such as the size of the microcarriers, the conditions enabling the coating of the microparticles and the subsequent adhesion of cells were thus studied to produce optimized PAM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15621263     DOI: 10.1016/j.biomaterials.2004.09.042

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

Review 1.  New strategies for improving stem cell therapy in ischemic heart disease.

Authors:  Peisen Huang; Xiaqiu Tian; Qing Li; Yuejin Yang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 2.  Nanostructured injectable cell microcarriers for tissue regeneration.

Authors:  Zhanpeng Zhang; Thomas W Eyster; Peter X Ma
Journal:  Nanomedicine (Lond)       Date:  2016-05-27       Impact factor: 5.307

3.  Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.

Authors:  Nicolas Daviaud; Elisa Garbayo; Laurence Sindji; Alberto Martínez-Serrano; Paul C Schiller; Claudia N Montero-Menei
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

4.  In vitro cell delivery by gelatin microspheres prepared in water-in-oil emulsion.

Authors:  Nicola Contessi Negrini; Maria Veronica Lipreri; Maria Cristina Tanzi; Silvia Farè
Journal:  J Mater Sci Mater Med       Date:  2020-02-14       Impact factor: 3.896

Review 5.  Spheramine for treatment of Parkinson's disease.

Authors:  Natividad P Stover; Ray L Watts
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

6.  Polymeric implant materials for the reconstruction of tracheal and pharyngeal mucosal defects in head and neck surgery.

Authors:  Dorothee Rickert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-03-10

7.  Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers.

Authors:  Elisa Garbayo; Ami P Raval; Kevin M Curtis; David Della-Morte; Lourdes A Gomez; Gianluca D'Ippolito; Teresita Reiner; Carlos Perez-Stable; Guy A Howard; Miguel A Perez-Pinzon; Claudia N Montero-Menei; Paul C Schiller
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.546

8.  Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease.

Authors:  Ming Ming; Xuping Li; Xiaolan Fan; Dehua Yang; Liang Li; Sheng Chen; Qing Gu; Weidong Le
Journal:  J Transl Med       Date:  2009-06-28       Impact factor: 5.531

9.  Microsphere controlled drug delivery for local control of tooth movement.

Authors:  Inna Sydorak; Ming Dang; Sarah J Baxter; Michael Halcomb; Peter Ma; Sunil Kapila; Nan Hatch
Journal:  Eur J Orthod       Date:  2019-01-23       Impact factor: 3.075

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.